These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Effect of intraarterial papaverine or nimodipine on vessel diameter in patients with cerebral vasospasm after subarachnoid hemorrhage. Kerz T; Boor S; Beyer C; Welschehold S; Schuessler A; Oertel J Br J Neurosurg; 2012 Aug; 26(4):517-24. PubMed ID: 22303863 [TBL] [Abstract][Full Text] [Related]
63. Neurodegenerative cerebrospinal fluid biomarkers tau and amyloid beta predict functional, quality of life, and neuropsychological outcomes after aneurysmal subarachnoid hemorrhage. Joswig H; Korte W; Früh S; Epprecht L; Hildebrandt G; Fournier JY; Stienen MN Neurosurg Rev; 2018 Apr; 41(2):605-614. PubMed ID: 28890998 [TBL] [Abstract][Full Text] [Related]
64. Effects of 14 Versus 21 Days of Nimodipine Therapy on Neurological Outcomes in Aneurysmal Subarachnoid Hemorrhage Patients. Cho S; Bales J; Tran TK; Korab G; Khandelwal N; Joffe AM Ann Pharmacother; 2016 Sep; 50(9):718-24. PubMed ID: 27273676 [TBL] [Abstract][Full Text] [Related]
65. Serum levels of nimodipine in enteral and parenteral administration in patients with aneurysmal subarachnoid hemorrhage. Abboud T; Andresen H; Koeppen J; Czorlich P; Duehrsen L; Stenzig J; Westphal M; Regelsberger J Acta Neurochir (Wien); 2015 May; 157(5):763-7. PubMed ID: 25701099 [TBL] [Abstract][Full Text] [Related]
66. Nimodipine for the prevention of cerebral vasospasm after subarachnoid hemorrhage in 12 children. Heffren J; McIntosh AM; Reiter PD Pediatr Neurol; 2015 Mar; 52(3):356-60. PubMed ID: 25585913 [TBL] [Abstract][Full Text] [Related]
67. Prophylactic intravenous nimodipine treatment in skull base surgery: pharmacokinetic aspects. Scheller C; Vogel AS; Simmermacher S; Rachinger JC; Prell J; Strauss C; Reinsch M; Kunter U; Wienke A; Neumann J; Scheller K J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):153-9. PubMed ID: 22241592 [TBL] [Abstract][Full Text] [Related]
68. Nimodipine in subarachnoid hemorrhage. DiPalma JR Am Fam Physician; 1989 Dec; 40(6):143-5. PubMed ID: 2686374 [TBL] [Abstract][Full Text] [Related]
75. The rise of soluble platelet-derived growth factor receptor β in CSF early after subarachnoid hemorrhage correlates with cerebral vasospasm. Liu JP; Ye ZN; Lv SY; Zhuang Z; Zhang XS; Zhang X; Wu W; Mao L; Lu Y; Wu LY; Fan JM; Tian WJ; Hang CH Neurol Sci; 2018 Jun; 39(6):1105-1111. PubMed ID: 29637448 [TBL] [Abstract][Full Text] [Related]
76. The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage. Moritz S; Warnat J; Bele S; Graf BM; Woertgen C J Neurosurg Anesthesiol; 2010 Jan; 22(1):21-31. PubMed ID: 20027011 [TBL] [Abstract][Full Text] [Related]
77. Continuous intra-arterial infusion of nimodipine at the onset of resistant vasospasm in aneurysmal subarachnoidal haemorrhage. Technical report. Doukas A; Petridis AK; Barth H; Jansen O; Mehdorn HM Neurol Res; 2011 Apr; 33(3):290-4. PubMed ID: 20626962 [TBL] [Abstract][Full Text] [Related]
78. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm. Hänggi D; Eicker S; Beseoglu K; Behr J; Turowski B; Steiger HJ Cent Eur Neurosurg; 2009 May; 70(2):61-7. PubMed ID: 19711257 [TBL] [Abstract][Full Text] [Related]
79. Monocyte chemoattractant protein-1 predicts outcome and vasospasm following aneurysmal subarachnoid hemorrhage. Kim GH; Kellner CP; Hahn DK; Desantis BM; Musabbir M; Starke RM; Rynkowski M; Komotar RJ; Otten ML; Sciacca R; Schmidt JM; Mayer SA; Connolly ES J Neurosurg; 2008 Jul; 109(1):38-43. PubMed ID: 18593272 [TBL] [Abstract][Full Text] [Related]